Stronger Neo-Minophagen C injection
Marketed by Dexa Medica
Product packaging may vary from one country to another.
Ingredients in every 20 ml
| Glycyrrhizic acid | 40 mg |
| Glycine | 400 mg |
| L-Cysteine | 20 mg |
Each package contains
30 ampoules of 20 ml
Other details
Dosage form:Injection
| Flavour | None |
W.H.O. classification
| ATC Level 1 | A - Alimentary tract and metabolism |
| ATC Level 2 | A05 - Bile and Liver Therapy Drugs |
| ATC Level 3 | A05C - Drugs for Bile Therapy and Lipotropics in Combination |
Warnings
Pregnancy
CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.
Lactation
CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.
Available in
 |
Indonesia |
Dosage information
OTHER DETAILS
In chronic hepatic diseases, the daily dosage is from 40 to 60 ml once a day by intravenous injection or intravenous drip infusion. The dosage may be adjusted depending on patient's age and symptom. If an increased dosage id necessary, the daily dosage should be kept within the limit of 100 ml.
In the experience of the clinical use, the occuring frequency of the adverse reactions such as hypopotassemia tends to be higher in the elderly. Careful administration shold be required with observation of patient's condition.
Indication
Improvement of abnormal hepatic function in chronic hepatic diseases.